153
Participants
Start Date
January 31, 2026
Primary Completion Date
February 28, 2027
Study Completion Date
November 30, 2027
Sevoflurane
Included patients, randomized in experimental group, intravenous sedation will be interrupted and followed by a 4 hour sedation with the volatile anesthetic sevoflurane.
Control Group
Included patients randomized in control group, intravenouse sedation is continued with propofol
Stadtspital Triemli, Zurich
Kantonasspital Münsterlingen, Münsterlingen
University Hospital of Zurich, Zurich
Waidspital Zürich, Zurich
Kantonsspital Münsterlingen
OTHER
Triemli Hospital
OTHER
Waid City Hospital, Zurich
OTHER
University of Zurich
OTHER